| SKU | ISG000913 |
| Brand | دولسيل |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 2 Mg |
| Shop by Concerns | Diabetes Complications Risk |
| Gender | Neutral |
| Shop By Goals | Blood Thinning |
| Imported Or Local | Local |
| Ingredient | Glimepiride |
| UPC | 6221508018128 |
| Product Form | Tablets |
| Specialty | Diabetes Oral Antidiabetic Sulfonylurea |
| Sub Categories | Insulin And Diabetic Medicines |
| Unit Count | 30 Tablets |
| Warning | Contraindicated in diabetic ketoacidosis Not for type 1 diabetes Use with caution in liver and kidney impairment Risk of hypoglycemia |
Dolcyl 2 Mg 30 Tablets
Description:
Dolcyl 2 mg 30 tablets is an oral antidiabetic medicine containing glimepiride, a sulfonylurea used for the long-term management of type 2 diabetes mellitus. It helps control high blood sugar levels in adults by stimulating the pancreas to release more insulin, thereby improving blood glucose control. Dolcyl 2 mg is typically used in combination with a proper diet, regular physical activity, and sometimes with other antidiabetic medications as prescribed by a healthcare professional. It is part of comprehensive diabetes care aimed at reducing the risk of diabetes-related complications such as kidney damage, nerve problems, and cardiovascular disease.
Indications:
- Management of type 2 diabetes mellitus in adults when blood glucose levels cannot be adequately controlled by diet, exercise, and weight reduction alone.
- Helps reduce elevated fasting and postprandial (after-meal) blood glucose levels.
- May be used as monotherapy or in combination with other oral antidiabetic agents (such as metformin) or insulin, as directed by the physician.
- Aims to lower the risk of long-term diabetes complications including neuropathy, nephropathy, retinopathy, and cardiovascular events, when used as part of an overall diabetes management plan.
Active Ingredients / Key Components:
- Glimepiride – 2 mg per tablet
- Excipients: Information on inactive ingredients (excipients, fillers, coloring agents, preservatives) is not available in the provided data. Please refer to the package leaflet for the full list of excipients.
Dosage & Administration / How to Use:
- Recommended starting dose: 1–2 mg once daily, as prescribed by the doctor.
- Usual dose for this product strength: Dolcyl 2 mg is commonly taken once daily, with the dose individualized based on blood glucose response.
- Maximum dose (per provided information): 2 mg/day, unless your doctor specifically adjusts your regimen. Always follow your physician’s instructions.
- Administration: Take the tablet once daily with food, usually with breakfast or the first main meal of the day, to reduce the risk of low blood sugar (hypoglycemia).
- Swallow the tablet whole with a sufficient amount of water. Do not crush or chew unless advised by your healthcare provider.
- If a dose is missed, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose. Do not double the dose to make up for a missed one.
- Regular monitoring of blood glucose and HbA1c is recommended to adjust the dose and ensure optimal control.
- Use this medication exactly as prescribed by your doctor. Do not change the dose or stop treatment without medical advice.
Clinical Benefits:
- Helps achieve and maintain better blood sugar control in adults with type 2 diabetes.
- Stimulates insulin secretion from functioning pancreatic beta cells, improving the body’s use of glucose.
- Supports long-term diabetes management when combined with diet, exercise, and lifestyle modifications.
- May help reduce the risk of diabetes-related complications such as kidney damage, nerve damage, eye problems, and cardiovascular disease when blood sugar is kept within target ranges.
- Convenient once-daily oral tablet for easier adherence to treatment.
Warnings & Contraindications:
- Contraindicated in patients with diabetic ketoacidosis (with or without coma). Such conditions require insulin therapy and urgent medical care.
- Contraindicated in patients with known hypersensitivity or allergy to glimepiride, other sulfonylureas, sulfonamides, or any component of the product.
- Not suitable for patients with type 1 diabetes mellitus.
- Use with caution in patients with severe liver or kidney impairment; dose adjustment or alternative therapy may be required.
- May cause hypoglycemia (low blood sugar), especially in elderly patients, those with irregular meals, intense physical activity, or when used with other antidiabetic drugs or alcohol.
- Symptoms of hypoglycemia include sweating, tremor, hunger, dizziness, palpitations, headache, confusion, and in severe cases, loss of consciousness. Immediate intake of fast-acting carbohydrates (e.g., glucose, sugary drink) is recommended if hypoglycemia occurs.
- Alcohol intake may enhance or weaken the blood sugar-lowering effect and should be limited or avoided.
- Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding. Insulin is often preferred in these situations.
- Use with caution in patients with G6PD deficiency due to risk of hemolytic anemia (class effect of sulfonylureas).
- May affect the ability to drive or operate machinery if hypoglycemia occurs. Avoid such activities if you experience warning signs of low blood sugar.
- Inform your doctor about all other medications you are taking, including other antidiabetics, beta-blockers, ACE inhibitors, diuretics, corticosteroids, and anticoagulants, as interactions may alter blood sugar control.
- Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as liver disease, kidney disease, adrenal or pituitary insufficiency.
- Not intended to diagnose, treat, cure, or prevent any disease beyond its approved indication for type 2 diabetes management.
- Keep out of reach of children.
Side Effects:
- Common side effects: Hypoglycemia (low blood sugar), headache, dizziness, nausea, vomiting, abdominal pain, and feeling weak.
- Less common side effects: Allergic skin reactions such as rash, itching, redness, or urticaria.
- Rare but serious side effects: Severe hypoglycemia, jaundice, liver function disturbances, blood disorders (e.g., thrombocytopenia, leukopenia, hemolytic anemia), severe allergic reactions (angioedema, anaphylactic reactions).
- Stop the medication and seek immediate medical attention if you experience severe dizziness, confusion, loss of consciousness, breathing difficulties, swelling of the face or throat, or yellowing of the skin or eyes.
- If any side effect persists or worsens, or if you notice any other unusual symptoms, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Store at or below the temperature indicated on the pack (specific temperature information is not available in the provided data; refer to the product carton or leaflet).
Specifications:
- Product type: Oral antidiabetic medicine (sulfonylurea).
- Strength: 2 mg glimepiride per tablet.
- Form: Tablet.
- Pack size: 30 tablets per pack.
- Intended users: Adults with type 2 diabetes mellitus, as prescribed by a healthcare professional.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.



